High-intensity Functional Training on Functional and Cognitive Performance in People with Parkinson's Disease.
NCT06879821
Summary
Parkinson's disease (PD) is a progressive and chronic neurodegenerative disease, which presents signs and symptoms both motor (impaired gait, posture, balance, etc.) and cognitive (memory loss, dementia, etc.), all of which are causing disability and assuming a high economic cost. Currently, there are already certain authors who have shown how a high-intensity interval training (HIIT) protocol produces improvements in cognitive and physical performance in healthy adults6 and in people with multiple sclerosis. However, another modality has been created, such as high-intensity functional training (HIFT), which can benefit different populations, both healthy and pathological, due to the multimodal nature of the exercises. Thanks to multimodality, more aspects such as agility, coordination and precision of movements are worked on compared to unimodal HIIT programs that make this relevant work difficult in a person's daily life. The current study aims to demonstrate the effectiveness of a HIFT training protocol in a specific population, such as people with Parkinson's disease.
Eligibility
Inclusion Criteria: * Diagnosis of Parkinson's disease. * Stage I or II (Hoehn - Yahr Scale). * Age between 45 and 80 years. * Independent ambulation for 10 consecutive minutes. * Regular physical exercise. Exclusion Criteria: * Medical contraindication for physical activity, deafness or limited hearing and very low vision or blind. * Vestibular disorders that compromise balance. * Psychotic or severe cognitive disorder. * Decompensation or changes in medication. * Surgical intervention in the last 6 months. * Sedentary persons
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06879821